J147

CAS No. 1146963-51-0

J147 ( J147; J 147; J-147 )

Catalog No. M10519 CAS No. 1146963-51-0

J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 In Stock
10MG 85 In Stock
25MG 141 In Stock
50MG 210 In Stock
100MG 312 In Stock
500MG 737 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    J147
  • Note
    Research use only, not for human use.
  • Brief Description
    J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
  • Description
    J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
  • Synonyms
    J147; J 147; J-147
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    BDNF
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1146963-51-0
  • Formula Weight
    350.34
  • Molecular Formula
    C18H17F3N2O2
  • Purity
    >98%(HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C(N(C1=CC=C(C)C=C1C)/N=C/C2=CC=CC(OC)=C2)C(F)(F)F
  • Chemical Name
    2,2,2-Trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lapchak PA, et al. J Neurol Neurophysiol. 2013 Aug;4(3). pii: 158.
molnova catalog
related products
  • C-82

    C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.

  • 2-methyl-2,3,4,5-tet...

    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.

  • FHD-286

    FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.